Cargando…
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition
Diabetic nephropathy is one of the most important microvascular complications of diabetes mellitus and is responsible for 40–50% of all cases of end stage renal disease. The therapeutic strategies in diabetic nephropathy need to be targeted towards the pathophysiology of the disease. The earlier the...
Autores principales: | Haller, Hermann, Ji, Linong, Stahl, Klaus, Bertram, Anna, Menne, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634607/ https://www.ncbi.nlm.nih.gov/pubmed/29082239 http://dx.doi.org/10.1155/2017/1909258 |
Ejemplares similares
-
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
por: Njau, Florence, et al.
Publicado: (2020) -
Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
por: Njau, Florence, et al.
Publicado: (2020) -
Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1
por: ZHANG, XIAOQIAN
Publicado: (2013) -
Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease
por: Zhang, Hao, et al.
Publicado: (2021)